Filling Small Batches

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2021
Volume 2021 eBook
Issue 2
Pages: 14-17

Advances in automation and cleanroom technology improve efficiency for small commercial quantities of aseptically filled drug products.

With the increase in drug products targeted to specific patient groups, including orphan drugs and even individualized medicine, manufacturers must consider how to optimize the manufacturing process for aseptic fill/finish of drugs in small batch sizes. Pharmaceutical Technology spoke with Joerg Zimmermann, vice-president of Development Service and External Affairs at Vetter, about these challenges and the equipment and facility options to consider.

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.

About the Author

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 14–17

Citation

When referring to this article, please cite it as J. Markarian, “Filling Small Batches" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).

Articles in this issue
IVAN TRAIMAK - STOCK.ADOBE.COM
Sterile Filtration: Reducing Risk, Ensuring Safety
nordroden - stock.adobe.com
Filling Small Batches
Vangelis Vassalakis - Stock.adobe.com
Breaking the Cold Chain for Vaccines
Kateryna_Kon/Stock.adobe.com – Image of Mycoplasma bacteria
Using ddPCR to Detect Mycoplasma Contamination
DARIAREN - STOCK.ADOBE.COM
The Impact of COVID-19 on Biologics Regulations
liga258 - Stock.adobe.com
Packaging Biologic Drugs for Clinical Trials
Daniel - stock.adobe.com
Tracking Technologies Guard Vaccine Cold Chain
Eyeing Up Success in Fill/Finish
Eyeing Up Success in Fill/Finish
ALEXNGM - STOCK.ADOBE.COM
Reducing Packaging Costs for Prefilled Syringes
putilov_denis - Stock.adobe.com
Biologics Facilities Expand and Establish New Locations in 2021
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Feliza Mirasol
November 15th 2024
Article

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone

Feliza Mirasol
November 13th 2024
Article

Under an ongoing partnership with Merck, known as MSD outside of the United States and Canada, Ginkgo Bioworks has achieved the first milestone in a project aimed at improving biologics production.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

TrakCel’s OCELLOS Platform Selected to Support Treatment Management of Five Upcoming Cell Therapy Products

Feliza Mirasol
November 13th 2024
Article

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.